BioConsortia, Inc., one of the leaders in microbial innovation for sustainable agriculture, announced on August 1, it has secured USD 15 million in funding from its long-standing internal investors, led by Otter Capital and affiliated funds.
“This investment, one in a series of recurring financings from our internal investors, reflects their deep confidence in BioConsortia’s science, strategy, and commercial momentum,” said Marcus Meadows-Smith, BioConsortia’s CEO. “Their investments total USD 95 million and bring BioConsortia to this exciting moment in the company’s history.”
The new funding will accelerate the global launch of Always-N, BioConsortia’s groundbreaking nitrogen-fixing seed treatment for industrial corn and support continued expansion of its discovery and development engine at the company’s Davis, California, headquarters.
Always-N enables farmers to maintain crop yields while reducing reliance on synthetic nitrogen fertilisers—significantly lowering greenhouse gas emissions and improving soil health. Applied as a seed treatment, Always-N delivers consistent field performance and is the only nitrogen-fixing biofertilizer combining advanced gene editing and extended viability exceeding two years.
“Synthetic nitrogen fertilisers are essential to modern agriculture, but their overuse comes at a steep environmental cost,” said Meadows-Smith. “With Always-N, we offer a powerful, sustainable alternative—backed by cutting-edge science and built for real-world performance.”
Roughly half of the applied synthetic nitrogen is never absorbed by crops. Instead, it runs off into waterways or is broken down in soil, releasing nitrous oxide—a greenhouse gas 300 times more potent than CO₂. As regulatory and market pressure build for climate-smart farming, demand for sustainable alternatives like Always-N is growing rapidly.
Following its successful commercial debut in New Zealand in 2024, Always-N is now preparing for broader market entry, supported by key global partners, including The Mosaic Company in row crops in the Americas. The new funding enables BioConsortia to scale manufacturing, build inventory, and expand market access in anticipation of the upcoming growing season.
Always-N is powered by BioConsortia’s discovery and development platform – an integrated engine using proprietary tools for microbial discovery, selection, and optimisation. It begins with Advanced Microbial Selection (AMS) to identify high-performing plant-associated microbes, then uses GenExpress and GenePro tools to enhance traits such as nitrogen fixation, disease and pest control, and shelf-life.
In addition to Always-N, BioConsortia is advancing a robust pipeline of next-generation biostimulants, fungicides, nematicides, and insecticides—engineered for extended shelf life, ease of use, and superior field efficacy.
Since its founding in 2014, BioConsortia has validated its platform across diverse crops, geographies, and soil types. Field trials have consistently demonstrated the efficacy of its microbial biofertilizers, fungicides, nematicides, and insecticides—delivering growers new tools for sustainable, high-yield farming.
More related news:
Oort Energy secures GBP 5M Funding to set-up green hydrogen facility
Black & Veatch joins AHC to develop globlal hydrogen economy
Rio Tinto to launch biofuel seed farming for renewable diesel production in Australia
